Daniel E. Owens - Nov 15, 2022 Form 4 Insider Report for TREACE MEDICAL CONCEPTS, INC. (TMCI)

Role
Chief Human Resources Officer
Signature
Lisa Taylor as Attorney-in-fact for Dan Owens
Stock symbol
TMCI
Transactions as of
Nov 15, 2022
Transactions value $
-$83,446
Form type
4
Date filed
11/17/2022, 07:00 PM
Previous filing
Sep 2, 2022
Next filing
Dec 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMCI Common Stock Options Exercise $43.9K +6.25K +58.41% $7.03 17K Nov 15, 2022 Direct F1, F2
transaction TMCI Common Stock Sale -$127K -6.25K -36.87% $20.38 10.7K Nov 15, 2022 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMCI Stock Option Right to Buy Options Exercise $0 -6.25K -3.24% $0.00 186K Nov 15, 2022 Common Stock 6.25K $7.03 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 Includes 6,700 RSUs.
F3 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $20.3432 to $20.4338 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The stock option vests in equal annual installments over 4 years, commencing on February 2, 2022, with the last installment on February 2, 2025.